george church (@geochurch) 's Twitter Profile
george church

@geochurch

Professor @Harvard @MIT @PGorg @WyssInstitute tech dev: #CRISPR #NGS #BRAINi

ID: 137836269

linkhttp://arep.med.harvard.edu/gmc calendar_today27-04-2010 22:35:56

282 Tweet

56,56K Followers

21 Following

Frances Anastassacos (@fran_anastas) 's Twitter Profile Photo

Excited to share Nabla Bio is partnering with 3 of the world’s largest pharma cos to use integrated AI and wet-lab tech to design antibodies against challenging disease targets. Thrilled to also add Radical Ventures who led our $26M Series A to the family! bit.ly/4dDk4lP

Surge Biswas (@surgebiswas) 's Twitter Profile Photo

I’m speaking today at PEGS Summit, 5:10 pm, Eng Antibodies. Talk will cover new “solMPMP” tech from Nabla Bio where we use generative ML to create soluble proxies of valuable multipass membrane protein drug targets, and use these proxies to facilitate design of new biologics.

I’m speaking today at <a href="/PEGSboston/">PEGS Summit</a>, 5:10 pm, Eng Antibodies. Talk will cover new “solMPMP” tech from <a href="/nablabio/">Nabla Bio</a> where we use generative ML to create soluble proxies of valuable multipass membrane protein drug targets, and use these proxies to facilitate design of new biologics.
Eli Weinstein (@eliweinstein6) 's Twitter Profile Photo

I’m thrilled to announce: at JURA Bio, Inc. we’ve constructed a new kind of generative protein model, which allows us to manufacture its generated designs in the real world at petascale. Paper: static1.squarespace.com/static/66db3a5… Blog: jura.bio/blog/variation…

Surge Biswas (@surgebiswas) 's Twitter Profile Photo

Incredibly excited to share new results from Nabla Bio where we show we can design antibodies de novo for use in therapeutic discovery. We introduce JAM, an AI system we’ve developed to design de novo antibodies with good affinities, early stage developability, and function.

Andrew Payne (@andrew_c_payne) 's Twitter Profile Photo

E11 Bio is excited to share a major step towards brain mapping at 100x lower cost, making whole-brain connectomics at human & mouse scale feasible (🧠→🔬→💻). Critical for curing brain disorders, building human-like AI systems, and even simulating human brains. 1/N 🧵

David Sun Kong, Ph.D. (@davidsunkong) 's Twitter Profile Photo

I’m thrilled to announce that the application for the 2025 edition of our MIT Media Lab and global synthetic biology course, “How to Grow (Almost) Anything” is now open! Application link in thread 👇

I’m thrilled to announce that the application for the 2025 edition of our <a href="/medialab/">MIT Media Lab</a> and global synthetic biology course, “How to Grow (Almost) Anything” is now open! Application link in thread 👇
Dyno Therapeutics, Inc. (@dyno_tx) 's Twitter Profile Photo

We’re excited to announce that Roche has exercised its option to license one of our next-generation AI-designed AAV vectors for neurological diseases! 🧬🚀 More on this key milestone for AI in gene therapy: businesswire.com/news/home/2025…

We’re excited to announce that <a href="/Roche/">Roche</a> has exercised its option to license one of our next-generation AI-designed AAV vectors for neurological diseases! 🧬🚀

More on this key milestone for AI in gene therapy: businesswire.com/news/home/2025…
george church (@geochurch) 's Twitter Profile Photo

Species-defining differences (governmental and scientific) include a mixture of physical & physiological measures, breeding/food/ecosystem preferences, and DNA.  There is no magic number of changes in any of these categories. A single genetic change can cause speciation ... while

Ansa Biotechnologies (@ansabio) 's Twitter Profile Photo

One year ago: 600 bp Today: 50,000 bp We are now accepting early access orders for synthetic DNA up to 50 kb — delivered in <4 weeks. Build without limits and innovate without compromise with longer DNA: businesswire.com/news/home/2025…

One year ago: 600 bp
Today: 50,000 bp

We are now accepting early access orders for synthetic DNA up to 50 kb — delivered in &lt;4 weeks.

Build without limits and innovate without compromise with longer DNA: businesswire.com/news/home/2025…